TILT HoldingsTLLTF EBITDA Margin % is 8.13% as of Jun. 2025. The stock has 4 warning signs investors should review. Among 955 Drug Manufacturers companies, TILT Holdings ranks worse than 86.6% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. TILT Holdings's EBITDA for the
three
months ended in Jun. 2025 was $0.85 Mil. TILT Holdings's Revenue for the
three
months ended in Jun. 2025 was $10.49 Mil. Therefore, TILT Holdings's EBITDA margin for the quarter that ended in Jun. 2025 was 8.13%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
TILT Holdings EBITDA Margin % Related Terms
TILT Holdings EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for TILT Holdings's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TLLTF vs FLHLF, STEK, NXEN: EBITDA Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, TILT Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TILT Holdings EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TILT Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where TILT Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TILT Holdings (TLLTF) has a EBITDA Margin % of 8.13% as of Jun. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on TILT Holdings and its competitors. According to the industry distribution chart, TILT Holdings ranks #827 out of 955 companies in the Drug Manufacturers industry, placing it in the top 86.6%.
Is TILT Holdings' EBITDA Margin % too high?
TILT Holdings' current EBITDA Margin % is 8.13%. The Drug Manufacturers industry median EBITDA Margin % is 12.44. TILT Holdings' value of 8.13% is 34.6% below this industry median. Based on the distribution chart, TILT Holdings ranks #827 out of 955 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does TILT Holdings' EBITDA Margin % compare to FLHLF and STEK?
According to the Drug Manufacturers industry distribution chart, TILT Holdings ranks #827 out of 955 companies for EBITDA Margin %. This places TILT Holdings in the lower half of its industry. The industry median EBITDA Margin % is 12.44. TILT Holdings' value of 8.13% is 34.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.44, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TILT Holdings's current EBITDA Margin % of 8.13% is 34.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on TILT Holdings and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TILT Holdings's current EBITDA Margin % is 8.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TILT Holdings stock overvalued right now?
TILT Holdings (TLLTF) has a current EBITDA Margin % of 8.13%. The stock's GF Value™ is $0.02, compared to a current price of $0.00 — trading 99.5% below its estimated fair value. The current EBITDA Margin % is 8.13% and 34.6% below the Drug Manufacturers industry median of 12.44. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For TILT Holdings (TLLTF), the current EBITDA Margin % is 8.13% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TILT Holdings Inc is a business solutions provider to the cannabis industry. The company helps cannabis businesses build brands through a portfolio of companies providing technology, hardware, cultivation, and production. The operating segments of the company are Cannabis and Accessories. The majority of the revenue is generated from the Accessories segment which is engaged in the manufacturing and distribution of electronic, non-nicotine (i.e., cannabis) devices and systems. The company's geographical segments include the United States, Canada, and others, of which the majority of the revenue is generated from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TLLTF has been successfully added to your 